Mayer EL, Fesl C, Hlauschek D, Garcia-Estevez L, et al. Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/AB J Clin Oncol 2022 Jan 7:JCO2101918. doi: 10.1200/JCO.21.01918.
PMID: 34995105